ArticleGastroenterology2019

Nucleos(t)ide Analog Therapy of Chronic Hepatitis B and Liver Cancer Risk Reduction: Better Nucleotides than Nucleosides?

Pietro Lampertico et al.PubMed ↗Publisher ↗

No numbers read from the abstract.